SK119795A3 - Indole derivatives as 5-ht1a and/or 5-ht2 ligands - Google Patents
Indole derivatives as 5-ht1a and/or 5-ht2 ligands Download PDFInfo
- Publication number
- SK119795A3 SK119795A3 SK1197-95A SK119795A SK119795A3 SK 119795 A3 SK119795 A3 SK 119795A3 SK 119795 A SK119795 A SK 119795A SK 119795 A3 SK119795 A3 SK 119795A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- indole
- methoxy
- pyridylmethyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI930699A IT1271352B (it) | 1993-04-08 | 1993-04-08 | Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale |
| PCT/EP1994/001016 WO1994024125A1 (en) | 1993-04-08 | 1994-03-31 | Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK119795A3 true SK119795A3 (en) | 1996-04-03 |
Family
ID=11365694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1197-95A SK119795A3 (en) | 1993-04-08 | 1994-03-31 | Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5834493A (zh) |
| EP (1) | EP0694033A1 (zh) |
| JP (1) | JPH08508738A (zh) |
| CN (1) | CN1124960A (zh) |
| AU (1) | AU684276B2 (zh) |
| BG (1) | BG100040A (zh) |
| BR (1) | BR9406206A (zh) |
| CA (1) | CA2160020A1 (zh) |
| CZ (1) | CZ283398B6 (zh) |
| FI (1) | FI954734A0 (zh) |
| HU (1) | HUT74090A (zh) |
| IL (1) | IL109234A (zh) |
| IT (1) | IT1271352B (zh) |
| NO (1) | NO953967L (zh) |
| NZ (1) | NZ265055A (zh) |
| PL (1) | PL310995A1 (zh) |
| SG (1) | SG50507A1 (zh) |
| SK (1) | SK119795A3 (zh) |
| WO (1) | WO1994024125A1 (zh) |
| ZA (1) | ZA942383B (zh) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9420521D0 (en) * | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| BR9808740A (pt) * | 1997-05-09 | 2000-10-03 | Lundbeck & Co As H | Método para fabricação de sertindol |
| US6673827B1 (en) | 1999-06-29 | 2004-01-06 | The Uab Research Foundation | Methods of treating fungal infections with inhibitors of NAD synthetase enzyme |
| US6861448B2 (en) * | 1998-01-14 | 2005-03-01 | Virtual Drug Development, Inc. | NAD synthetase inhibitors and uses thereof |
| WO1999036422A1 (en) | 1998-01-14 | 1999-07-22 | The Uab Research Foundation | Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme |
| US6133287A (en) * | 1998-03-24 | 2000-10-17 | Allelix Biopharmaceuticals Inc. | Piperidine-indole compounds having 5-HT6 affinity |
| ES2182509T3 (es) * | 1998-04-08 | 2003-03-01 | Wyeth Corp | Derivados de n-ariloxietilamina para el tratamiento de la depresion. |
| JP2002513018A (ja) * | 1998-04-29 | 2002-05-08 | アメリカン・ホーム・プロダクツ・コーポレイション | セロトニン作動薬 |
| FR2799463B1 (fr) * | 1999-10-12 | 2004-04-16 | Adir | Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent |
| DE19951360A1 (de) * | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| PL363238A1 (en) | 2000-12-22 | 2004-11-15 | Wyeth | Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| US7135479B2 (en) | 2002-09-12 | 2006-11-14 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| CA2796756A1 (en) * | 2010-04-22 | 2011-10-27 | Intra-Cellular Therapies, Inc. | Substituted pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalines for the treatment of central nervous system disorders |
| EP2836213B1 (en) | 2012-04-14 | 2018-07-04 | Intra-Cellular Therapies, Inc. | Fused gamma carbolines |
| DK2968320T3 (da) | 2013-03-15 | 2021-02-01 | Intra Cellular Therapies Inc | Organiske forbindelser |
| IL305990A (en) | 2013-12-03 | 2023-11-01 | Intra Cellular Therapies Inc | Compressed gamma-carboline heterocyclic compounds are modified for use in the treatment of type I and/or type II bipolar disorders |
| KR20170012209A (ko) | 2014-04-04 | 2017-02-02 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| MX365969B (es) | 2014-04-04 | 2019-06-21 | Intra Cellular Therapies Inc | Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio. |
| WO2017023894A1 (en) * | 2015-08-03 | 2017-02-09 | Raze Therapeutics, Inc. | Mthfd2 inhibitors and uses thereof |
| DK3407888T3 (da) | 2016-01-26 | 2021-04-06 | Intra Cellular Therapies Inc | Pyridopyrroloquinoxalinforbindelser, deres sammensætninger og anvendelser |
| PL3407889T3 (pl) | 2016-03-25 | 2021-11-22 | Intra-Cellular Therapies, Inc. | Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego |
| WO2017172795A1 (en) | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
| WO2018071233A1 (en) | 2016-10-12 | 2018-04-19 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| WO2018126140A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
| EP3562484B1 (en) | 2016-12-29 | 2021-08-25 | Intra-Cellular Therapies, Inc. | Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline derivatives useful in the treatment of cns disorders |
| US10716786B2 (en) | 2017-03-24 | 2020-07-21 | Intra-Cellular Therapies, Inc. | Transmucosal and subcutaneous compositions |
| WO2019023063A1 (en) | 2017-07-26 | 2019-01-31 | Intra-Cellular Therapies, Inc. | ORGANIC COMPOUNDS |
| EP3658145A4 (en) | 2017-07-26 | 2021-04-21 | Intra-Cellular Therapies, Inc. | ORGANIC COMPOUNDS |
| WO2019237037A1 (en) | 2018-06-08 | 2019-12-12 | Intra-Cellular Therapies, Inc. | Novel methods |
| WO2020047241A1 (en) | 2018-08-29 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
| US10695345B2 (en) | 2018-08-31 | 2020-06-30 | Intra-Cellular Therapies, Inc. | Pharmaceutical capsule compositions comprising lumateperone mono-tosylate |
| CA3108553A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
| CA3141223A1 (en) | 2019-07-07 | 2021-01-14 | Sharon Mates | Novel methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0429341A3 (en) * | 1989-11-20 | 1991-11-13 | Rhone-Poulenc Sante | Heterocyclic derivatives, their preparation and pharmaceuticals containing them |
| DK0592438T5 (da) * | 1990-10-15 | 1999-12-06 | Pfizer Inc. | Indolderivater |
| JP3140155B2 (ja) * | 1992-03-09 | 2001-03-05 | 杏林製薬株式会社 | Ｎ，ｎ’−ジ置換アミド誘導体 |
| CA2092112A1 (en) * | 1992-03-23 | 1993-09-24 | Nobuyoshi Iwata | Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use |
-
1993
- 1993-04-08 IT ITMI930699A patent/IT1271352B/it active IP Right Grant
-
1994
- 1994-03-31 PL PL94310995A patent/PL310995A1/xx unknown
- 1994-03-31 CN CN94192345A patent/CN1124960A/zh active Pending
- 1994-03-31 JP JP6522684A patent/JPH08508738A/ja active Pending
- 1994-03-31 SG SG1996002949A patent/SG50507A1/en unknown
- 1994-03-31 BR BR9406206A patent/BR9406206A/pt not_active Application Discontinuation
- 1994-03-31 CZ CZ952602A patent/CZ283398B6/cs unknown
- 1994-03-31 SK SK1197-95A patent/SK119795A3/sk unknown
- 1994-03-31 US US08/530,354 patent/US5834493A/en not_active Expired - Fee Related
- 1994-03-31 NZ NZ265055A patent/NZ265055A/en unknown
- 1994-03-31 EP EP94913101A patent/EP0694033A1/en not_active Withdrawn
- 1994-03-31 AU AU65382/94A patent/AU684276B2/en not_active Ceased
- 1994-03-31 WO PCT/EP1994/001016 patent/WO1994024125A1/en not_active Application Discontinuation
- 1994-03-31 CA CA002160020A patent/CA2160020A1/en not_active Abandoned
- 1994-03-31 HU HU9502913A patent/HUT74090A/hu unknown
- 1994-04-06 IL IL109234A patent/IL109234A/en not_active IP Right Cessation
- 1994-04-07 ZA ZA942383A patent/ZA942383B/xx unknown
-
1995
- 1995-10-02 BG BG100040A patent/BG100040A/bg unknown
- 1995-10-05 NO NO953967A patent/NO953967L/no unknown
- 1995-10-05 FI FI954734A patent/FI954734A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT1271352B (it) | 1997-05-27 |
| FI954734A (fi) | 1995-10-05 |
| SG50507A1 (en) | 1998-07-20 |
| US5834493A (en) | 1998-11-10 |
| CN1124960A (zh) | 1996-06-19 |
| HUT74090A (en) | 1996-11-28 |
| JPH08508738A (ja) | 1996-09-17 |
| IL109234A0 (en) | 1994-07-31 |
| CZ260295A3 (en) | 1996-01-17 |
| NO953967L (no) | 1995-12-05 |
| WO1994024125A1 (en) | 1994-10-27 |
| EP0694033A1 (en) | 1996-01-31 |
| IL109234A (en) | 1998-04-05 |
| HU9502913D0 (en) | 1995-11-28 |
| BG100040A (bg) | 1996-03-29 |
| ZA942383B (en) | 1995-10-09 |
| FI954734A0 (fi) | 1995-10-05 |
| ITMI930699A0 (it) | 1993-04-08 |
| NZ265055A (en) | 1996-09-25 |
| CA2160020A1 (en) | 1994-10-27 |
| AU684276B2 (en) | 1997-12-11 |
| AU6538294A (en) | 1994-11-08 |
| CZ283398B6 (cs) | 1998-04-15 |
| ITMI930699A1 (it) | 1994-10-08 |
| PL310995A1 (en) | 1996-01-22 |
| NO953967D0 (no) | 1995-10-05 |
| BR9406206A (pt) | 1996-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK119795A3 (en) | Indole derivatives as 5-ht1a and/or 5-ht2 ligands | |
| JP2614981B2 (ja) | インドール、インダゾール及びベンズイソオキサゾール化合物、それらの製法およびそれらを含有する製薬組成物 | |
| US5618833A (en) | 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present | |
| US6747030B1 (en) | Piperazine derivatives as 5-HT1B antagonists | |
| JPH07504429A (ja) | ５ＨＴ↓１ｃアンタゴニストとしてのインドール誘導体 | |
| US5661169A (en) | 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and the pharmaceutical compositions containing them | |
| JP2006502985A (ja) | ムスカリン性受容体拮抗剤として有用な３，６−二置換アザビシクロ［３．１．０］ヘキサン誘導体 | |
| NZ523141A (en) | 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity | |
| EP0227241B1 (en) | Medicinal indole and indazole keto sulphone derivatives | |
| JP3898219B2 (ja) | フエニルインドール化合物 | |
| US5646279A (en) | Substituted 4-piperazinylmethyl 2-phenylimidazoles; dopamine receptor subtype specific ligands | |
| US6066637A (en) | Indolyl derivatives as serotonergic agents | |
| US5607957A (en) | Imidazole, triazole and tetrazole derivatives | |
| WO1993021179A1 (en) | Novel amidoalkyl- and imidoalkyl-piperazines | |
| JP2006503056A (ja) | ヒスタミンｈ３受容体アンタゴニスト、その製造および治療用使用 | |
| JPS6257606B2 (zh) | ||
| EP1073651B1 (en) | Indolyl derivatives as serotonergic agents | |
| US6057340A (en) | Oxazole derivatives as serotonin-1A receptor agonists | |
| KR101471987B1 (ko) | 일정한 ｃｎｓ-관련 질환을 치료하기 위한 2-알킬-인다졸 화합물 | |
| JPH06184074A (ja) | １−アルコキシナフタレン−２−カルボキサミド誘導体、その製法並びに該誘導体を含有する医薬組成物 | |
| KR100363484B1 (ko) | 3-치환1-아릴인돌화합물 | |
| WO1999055697A1 (en) | Serotonergic agents | |
| JPH0525140A (ja) | ベンズイミダゾール誘導体 | |
| JP3786984B2 (ja) | ピペラジン誘導体 | |
| US5047402A (en) | Cyclic amides as medicaments |